VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2022 | Lung cancer screening via biomarkers

Luis Montuenga, MD, Clinica Universidad de Navarra, Pamplona, Spain, discusses utilizing various molecular biomarkers in screening for lung cancer, including proteins circulating the blood and circulating tumor DNA (ctDNA), which can aid in defining risk levels of patients as low, intermediate, or high-risk. This interview took place during the virtual European Lung Cancer Congress 2022.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter